Open letter to Annette King, Minister of Health, New Zealand: Intensive medicines monitoring programme is not due to be stoppedBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7463.460-b (Published 19 August 2004) Cite this as: BMJ 2004;329:460
- Don Matheson, deputy director-general (Antony_Byers@moh.govt.nz)
- Public Health Directorate, Ministry of Health, New Zealand
EDITOR—Herxheimer is misleading in claiming that Medsafe, the New Zealand medicines regulator, is intending to stop funding the intensive medicines monitoring programme.1 In the past year, the ministry has provided additional funding to the New Zealand pharmacovigilance centre to intensively monitor the rollout of the meningococcal vaccine, which has been developed to …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial